Category Archives: LEDs

Click here to enlarge image

EMERYVILLE, Calif. Dec. 18, 2002 — Charlie Janac thinks his company, Nanomix Inc., could be nanotechnology’s first hit company — that is, once people figure out how to pronounce its name.

Click here to enlarge image

Nanomix, sounds like “genomics.”

Click here to enlarge image

“Our goal is to become so famous it’s not even a question,” said Janac, the company’s chief executive.

Click here to enlarge image

Nanomix, formerly Covalent Materials, is the brainchild of University of California, Berkeley, physicists Alex Zettl and Marvin Cohen. They developed a way to build carbon nanotube structures that act as chemical sensors. They are also working on developing hydrogen fuel tanks. Their primary strength has been using theoretical modeling to predict the behavior of nanostructures.

Janac thinks the company’s modeling expertise will make Nanomix a model for success in the nanotechnology business. In fact, Janac said, Nanomix might be for nanotechnology what Genentech Inc. was for biotech: the company that shows how to commercialize the science.

“Somebody has to create the model, and we think we have a rational model for getting from the lab to engineering to production to revenues to profit,” Janac said. It helps that Janac has an affinity for hard science (as a young researcher, he invented the backsheet for disposable diapers. He still grouses that his material of choice was passed over for something hundredths of a cent cheaper).

Nanomix has a long way to go before it can become nanotech’s Genentech. It’s out of the lab, but that’s just the first milestone. Next on the list: shipping test sensors to potential customers. That should happen in the first quarter of 2003. If it continues to hit its goals, Janac said, Nanomix will see its first revenues in 2003’s fourth quarter.

But big hurdles remain.

“The science is based on virtual reality — theoretical modeling — actually proving out in physical reality,” said Brock Hinzmann, technology navigator at SRI Consulting. “Engineering often takes a lot longer than what people think it should.”

Hinzmann said, too, that even if Nanomix nails the engineering and production issues, the company still has to figure out its business model, especially if it plans to sell $50 sensors into a market used to paying $3,000. That, of course, assumes it can get companies to adopt its technology, rather than those of competitors both inside and outside the nano space.

Hinzmann does think that Nanomix has a great scientific team, and said it may well get to market first.

Marc Rothchild, a senior analyst at San Francisco Consulting Group, said he believes that despite its challenges, “Nanomix has a good possibility of succeeding.” Its sensing technology has multiple applications, and he said the company has a good grasp on how to manufacture its products. “It’s just a matter of proving it.”

Janac is aware of the issues, and cautions that it will take Nanomix three to four years to generate positive cash flow. Nevertheless, he said, “we are probably going to be the first company to ship a complex nanodevice.”

Nanomix signed up some believers in September, landing a second round of funding for $9 million. Apax Partners and Sevin Rosen Funds led the round. EnerTech Capital Partners participated, as did first-round investor Alta Partners. Getting a second round of funding in the current market is significant, particularly for a nanotechnology firm.

“This round of funding gets us to production, or close to production, of our first product,” Janac says. “We’re taking the science out of the lab and into testing, real environments and market validation.”

The second round? Janac has a slide showing that it took nine months, 145 meetings with 41 venture funds, 21 different iterations of the company’s investor presentation and three term sheets. He estimates that he spent 80 percent of his time on closing the round. “I was talking to a VC the other day, and my wife asked me, ‘Why are you still talking to VCs?’ I told her, ‘I just can’t go cold turkey,'” Janac joked.

The truth is, Nanomix will eventually need more funding, at least some of it from strategic corporate investors. In particular, it will need to fund its work in hydrogen storage, which is where it thinks it has huge long-term potential. The company’s first prototype hydrogen fuel cell is hefty, and could only power a projector for a couple of hours. But it’s working on a new prototype.

For now, nanosensors are the focus of the business. If the model bears out, people will learn how to say Nanomix.

Click here to enlarge image

ZURICH, Switzerland, Dec. 17, 2002 — Just as organic fruit is good for your health, organic metals appear to be good for the environment. If some venture capitalists are right, these new materials will be good for the bottom line, too.

Click here to enlarge image

One of the first companies to commercialize these special kinds of conductive polymers is Ormecon GmbH, which actually trademarked the name “organic metal.” The term refers to a conductive polymer. It’s a highly engineered nanostructured material made from organic building blocks (typical organics are carbon, nitrogen or hydrogen).

Ormecon’s products belong to the sector of small tech known as nanoparticles, which according to Business Communications Company Inc., a market research firm, has a global market growing at an average annual rate of 12.8 percent. It is expected to reach $900.1 million in 2005.

Click here to enlarge image

The particles or crystals in its products are about 10 nanometers in size, created using a chemical process that Ormecon’s founder has been working on for more than 20 years. What’s different about these nanoparticles is that they are dispersed within various liquids. While other scientists were trying to dissolve the crystals in solvents, Bernhard Wessling figured out that they needed to be dispersed and made into ultrafine suspensions in liquids or polymers.

Ormecon’s products are used by a wide range of firms in a number of different industries, including printed circuit board manufacturers that use its coatings as an alternative to gold or tin finishes; shipbuilders that paint hulls with Ormecon’s anti-corrosion lacquers, and next-generation flat panel display vendors that are developing very cheap, high-resolution displays. Ormecon is also selling electromagnetic shielding coatings that manufacturers are painting onto mobile phones.

Although the firm is breaking even in “most quarters,” the company said, it decided to raise outside capital this year. The process took Wessling, Ormecon’s chief executive and founder, more than a year. “When you have something completely new, it is not easy to convince investors, especially these days,” Wessling said.

After a lot of sweat and effort on both sides of the due diligence table, the company finally closed a $7.5 million expansion capital round earlier last month, lead by SAM Private Equity.

Co-investors are the Canadian venture capital firm CDP Capital Technology Ventures, SAM Smart Energy and Future Capital AG in Frankfurt.

“Advanced materials is one of the hottest areas of nanotechnology, especially because they are often very close to real marketable applications,” said Christian Schmidt-Maag, whose investment firm, Capital Stage, has been “watching” Ormecon “for some time” but has not invested in the firm.

Ormecon will increase sales revenue this year by more than 50 percent over 2001, according to a news release by the investors. Future product lines could be coatings used in solar cells and electroluminescence applications.

Most of the revenues are earned in three application areas: anti-corrosion, electronic smog protection and printed circuit board solderable coatings. The latter sector is its biggest earner today. Korean makers of printed circuit boards are adopting its coatings for the final solderable surface finish.

The Ormecon coatings compete with industry standard approaches for finishing PCBs. One is tin dipping, which is a relatively low-tech process that is energy intensive and involves blowing excess molten solder from the PCB surface. It also contains lead, a material that regulatory agencies are clamping down on.

Ormecon’s technology is cleaner, cheaper and simpler to use. Gold surface finishing, the other method for coating PCBs, is superior to tin and works at very high circuit densities, but it is expensive. Compared to gold, Ormecon’s surface offers almost the same properties but at a third of the price, according to the firm.

Ormecon has agreements with Bayer and DuPont, as well as marketing deals with about 20 other industrial companies that are selling Ormecon’s products worldwide. It collaborates with Covion Organic Semiconductors GmbH, one of the key supplier of materials required to make OLED (organic light emitting diode) displays, which it sells to Cambridge Display Technology (CDT) and Philips, among others.

Stewart Hough, CDT’s vice president of business development, said that Covion is a key supplier of the materials needed to make OLEDs, but a number of organic polymers similar to Covion’s are emerging, made from different chemicals and via different processes.

Click here to enlarge image

SAN DIEGO, Dec. 16, 2002 — It’s long been said that among the great ironies of the California Gold Rush is that prospectors rarely got rich, but considerable fortunes were amassed by the enterprising merchants who sold the miners picks, shovels and Levi Strauss dungarees.

Click here to enlarge image

A century and a half later, the lesson has not been lost on San Diego-based Genicon Sciences Corp. and Pat Mallon, its chief executive. “From the business side, developing drugs takes a long time and it’s a circuitous route,” Mallon said. “I wanted to get into putting something in boxes. I like the financial aspects and if you do it with some new technology in a high-tech area, so much the better.”

Genicon’s picks-and-shovels play is a nanotechnology-based signal generation and detection tool kit for microarrays or DNA chips, which play a crucial role in drug discovery. Genicon’s Resonance Light Scattering (RLS) technology uses nanosize particles treated with chemicals that cling to genetic material. When the sample is exposed to light, the genes illuminate. Scientists use the data to test how cells react to drugs or diseases. Ultimately, doctors may use microarray technology to analyze a patient’s “genetic fingerprint” in the treatment of disease.

Click here to enlarge image

Mallon said Genicon’s method is far more sensitive than conventional technology, which uses fluorescent dyes to illuminate genes. “If you take a look at the Milky Way, a telescope might be able to show it to you and pick out a few of the brightest stars,” Mallon said. RLS technology, he said, can “pick out most of the stars in there.”

This summer, Genicon launched its first toolkit for microarrays, distributed by Qiagen NV. The technology has been tested at the Centers for Disease Control and Prevention, the U.S. Food and Drug Administration and the City of Hope Medical Center in Duarte, Calif.

For Mallon, it’s the end of an R&D journey, but the beginning of Genicon as a revenue generator. To date, the company has raised $36 million in venture capital from backers including San Diego-based Forward Ventures, Inglewood Ventures and Oxford Bioscience Partners.

Forward’s Joel Martin has a background in nanoscience as co-founder and chairman of Quantum Dot Corp., a pioneer in nanobiotech applications.

Mallon came to Genicon from a post as director of market development and planning at Agouron Pharmaceuticals Inc., and was an executive at Roche Laboratories, where he was responsible for the domestic marketing of HIV and oncology drugs.

Even with a better mousetrap, Mallon says Genicon must be able to deliver on its commercial potential by educating the biotech industry, and using the RLS technology to diversify into other bio tool kits expected to hit the market next year.

In the meantime, Genicon is back in the venture market for somewhere between $15 million and $25 million, but Mallon said he’s not worried about the current venture climate.

“Each time we’ve gone out to raise money has been the worst time,” he reflects, “and it keeps getting worse each time.”

Mallon said investors are looking for something more substantial than technological novelty. “This whole platform, whether you call it nano or micro doesn’t mean you’re getting better results. Just enhancing a process anybody can do, but getting a better biological result is something different. Nano is a word to us. Nano enables us to produce a better result.”

To investors at large, the jury is still out on companies in the drug discovery information business like Genicon, said John McCamant, editor of Berkeley Calif.-based Medical Technology Stock Letter. Though Genicon has key strengths such as a major distributor relationship with Qiagen and the ability to attract venture funding as it commercializes, McCamant said the allure of so-called “pick-and-shovel” companies is overrated.

The advantage of pick and shovel companies in comparison with drug discoverers is a huge “canard,” McCamant said that an irrationally exuberant market attracted millions of venture dollars to flash-in-the-pan genomics companies. “There’s only so much data people need,” McCamant said. “The information companies have got to show their technology is a real advance.”

Neil Gordon, an expert in nanomaterials at Sygertech Consulting Group and president of the Canadian NanoBusiness Alliance, said Genicon has hit on “a great idea and the approach seems very simple.

“In theory, it sounds phenomenal,” he said. “It will be one or more rounds until these guys are self-sufficient. They have good investors and good partners. They’ve had a lot of money thrown at them, but they have a high burn rate of $3.5 million to $4 million a month.”

Gordon doesn’t see any immediate winner in the competition between Genicon’s RLS, quantum dot technology and fluorescent dye methods. “The assay system market is going to fragment and different solutions will be optimal for different approaches,” Gordon said.

“It’s an exciting area, but there’s a big difference between a science project and a commercial venture. Numerous risks and obstacles have to be overcome, including time to market.”


null

Company file: Genicon Sciences Corp.
(last updated Dec. 16, 2002)

Company
Genicon Sciences Corp.

Headquarters
11535 Sorrento Valley Road
San Diego, Calif., 92121

History
The company was incorporated in June 1998. At that time, CEO Pat Mallon joined the company from San Diego-based Agouron Pharmaceuticals Inc. Genicon recently launched its first commercial product, a nanotech-based signal generation and detection system for microarrays and other tests used in drug discovery.

Industry
Medical lab instruments

Employees
83

Small tech-related products and services
Genicon’s flagship product is its One-Color Microarray Toolkit. Its Resonance Light Scattering (RLS) technology uses metallic nanoparticles, which cling to genetic material and scatter light upon illumination, aiding analysis of microarrays or DNA chips. The customizable technology is applicable to proteomics, drug discovery and cell studies.

Management

  • Patrick Mallon: president and chief executive officer
  • Janine Taylor: chief operating officer and chief financial officer
  • Juan Yguerabide: vice president of discovery
  • Richard Anderson: vice president of product development
  • Selected strategic partners and customers

  • BD Biosciences Clontech Inc.
  • Genomics Institute of the Novartis Research Foundation
  • Qiagen NV
  • Investment history
    According to VentureSource, Genicon picked up $4.5 million in a 1998 financing round, with a $2.5 million round following in 1999. In 2001, it garnered $33 million from nine corporate investors. Key investors include:

  • Oxford Bioscience Partners
  • Utah Venture Partners
  • Forward Ventures (largest stakeholder)
  • Competitors
    Genicon competes with firms that make microarray detection systems based on fluorescent dyes or other technologies. Selected competitors:

  • Arradial Inc.
  • Dyomics GmbH
  • Molecular Staging Inc.
  • ViaLogy Corp.
  • Zeptosens AG
  • Goals
    In the crucial 12-24 month timeframe, Mallon says, he wants to launch a variety of nucleic acid, gene expression, protein, DNA and other tool kits and hopes to get to “cash-break-even” status.

    What keeps them up at night
    “I have no problem coming to work each day, so nothing keeps me up at night,” Mallon says.

    Recent news and publications
    Genicon, German firm market DNA nanochip

    Patent
    Analyte assay using particulate labels

    Contact

  • URL: www.geniconsciences.com
  • Phone: 858-793-0276
  • Fax: 858-793-6791
  • E-mail: [email protected]
  • — Research by Gretchen McNeely

    Dec. 16, 2002 — DuPont Displays and Universal Display Corp. (UDC) said they plan to jointly develop a new generation of organic light-emitting diode (OLED) materials and technology.

    The Wilmington, Del.-based unit of DuPont and Ewing, N.J.-based UDC have signed a cross-license agreement, in which DuPont Displays will make an initial payment to UDC and pay a running royalty for products sold using UDC’s technology. The firms expect to use a subcontractor to make the materials, according to a news release.

    The companies said they believe that UDC’s phosphorescent OLED technology and DuPont Displays’ expertise in polymer science and optical components will offer higher performance and lower costs than current methods. The partnership also could enable OLEDs, which are made using thin, nanostructured polymer films, to capture an increased share of the $30 billion flat-panel display market, the release said.

    Dec. 11, 2002 – Wilmington, DE, and Ewing, NJ – DuPont Displays, a business unit of DuPont and a developer and manufacturer of polymer OLED displays, together with Universal Display Corp. (UDC), an innovator of OLED technologies, have signed a joint development agreement to create a new generation of soluble OLED materials and technology.

    UDC and DuPont have also executed a cross-license agreement, under which DuPont will make an initial payment to UDC and pay UDC a running royalty for products sold that utilize UDC’s background phosphorescent emitter, transparent cathode, and ink jet printing technologies.

    The joint development agreement establishes an IP collaboration aimed at combining elements of both small molecule OLED and solution processible OLED research. DuPont intends to use the results of this strategic alliance to expand its OLED manufacturing capability. UDC, in turn, will have the exclusive right to license the results of the collaboration to third parties.

    Dec. 11, 2002 — Scientists say they have conquered technical challenges that have stymied attempts to put quantum dots to work in biological imaging.

    A trio of recent publications herald new achievements in using the inorganic fluorescent probes to shed light on cellular processes that have until now been viewed only briefly and dimly with the aid of organic dyes.

    A publication in Science and two released online in Nature Biotechnology say quantum dot technology is ready to pay off on promises that it can be used to image multiple proteins and structures inside cells. Research results indicate that quantum dots are brighter, longer-lasting, more specific biomarkers than the organic dyes currently in use.

    Click here to enlarge image

    “This is fascinating,” said Tom Petzinger, chief executive of Bioplex Corp., which is working on technology to aggregate quantum dots in beads, and on other biomedical uses of the semiconductor nanocrystals. Evidence that the nanoparticles did not distort the processes of living cells even after more than a week’s observation was particularly important to advancing the state of the science, Petzinger said..

    Bioplex, owned in part by Pittsburgh’s LaunchCyte incubator, is one of only a few companies known to be working on quantum dot technology. Another, Quantum Dot Corp. of Hayward, Calif., is behind one of the Nature Biotechnology papers, along with Genentech Inc., the South San Francisco biotech powerhouse.

    Just weeks before the paper came out, Quantum Dot launched its first nano-biotech product, the Qdot 605 Streptavidin Conjugate, semiconductor nanocrystals attached to a specific biomolecule for use in cell and tissue analysis.

    “Before, the potential for quantum dots to label specific targets inside cells was a concept, but it had never been demonstrated,” said Quantum Dot scientist Xingyong Wu. “We showed that we actually can do it. Right now it can be used in real applications.”

    Early attempts to label cellular targets linked quantum dots to biotin or the protein transferrin. Results were unsatisfactory: the labeling signal was weak and targeting was not as specific as testers hoped.

    Wu and other Quantum Dot researchers, working with scientists from Genentech, resolved problems in surface coating and successfully labeled a number of targets. Quantum dots selectively and distinctly illuminated the breast cancer marker Her2, nuclear antigens and other subcellular structures in their research.

    Quantum Dot plans to have three or four more products on the market within months, Wu said.

    Academic and military scientists formed the team for the second Nature Biotechnology article. They were on a mission to refine quantum dot technology to make it generally available and workable in a broad range of uses. They succeeded, according to a researcher.

    “The technique that we have developed is ready to use,” said Sanford M. Simon of Rockefeller University in New York. Working with the U.S. Naval Research Laboratory, Rockefeller scientists induced living cells to assimilate quantum dots, then tracked the marked cells for more than a week.

    Their techniques for selectively and noninvasively tagging living cells using the semiconductor dots were designed with an eye to general use.

    “The applications are all over the map in biology,” Simon said.

    As promised, the inorganic fluorophores that are quantum dots held their fluorescence longer and burned more brightly than their organic dye counterparts in the Rockefeller/Navy experiments. Susceptible to more fine-tuning than organic dyes, the dots selectively labeled different proteins with different colors.

    More than a week’s observation revealed no sign that the quantum dots affected cell processes, either. Marked cells grew, developed and signaled as usual, meaning the quantum dots could literally shed light on the processes of life at the subcellular level without influencing it.

    “The paper is in a form that makes it possible for anyone to use the techniques,” said investigator Jyoti K. Jaiswal, also of Rockefeller. Prior to this work, imaging technology would only allow brief, indistinct glimpses of crude cellular interaction, he explained. Now scientists can watch a number of different processes at once by way of quantum dot enhanced live cell imaging, he said.

    “We know cells move around, talk to each other, interact, and in some sense influence each other,” Jaiswal said. “We don’t understand how these interactions come about. For that purpose we have to monitor the cells in real time, watch them as the interaction goes on.”

    A third team of researchers reported their solution to the biocompatibility problem in Science. They sheathed the dots in phospholipid membranes and hooked them to DNA to produce clear images in growing embryos, where the nanocrystals appeared stable and nontoxic.

    “These three papers combined indicate that bioconjugate nanocrystals will have major applications in biology and medicine,” said Shuming Nie, director of nanotechnology at Emory University’s Winship Cancer Institute.

    Nie also serves as senior science consultant to Bioplex, which licensed nanobead technology he had developed. Dots aggregated into beads are encoded to enhance multiplexing capabilities, expanding the potential for tagging multiple targets simultaneously.

    Zia Laser secures $5.5 million


    December 11, 2002

    Dec. 11, 2002 — Zia Laser Inc., an Albuquerque, N.M., developer of quantum dot lasers, has received $5.5 million in an ongoing second round of financing, according to a report in the Albuquerque Journal. Investors in the round include RWI Group and Prism Venture Partners. Both are existing investors.

    A spokesman for the company said the round will be officially announced when it closes in 90 days. Zia Laser previously received $6 million in financing in 2001.

    Zia’s lasers use semiconductor nanostructures known as quantum dots to generate laser beams, which are used to send data over optical communications systems.

    Electronics packaging materials suppliers traditionally have functioned as developers of continuously evolving formulations that enhance both component and assembly performance and reliability. Applications such as encapsulating, bonding, stress relief, heat dissipation and others have led to the development of packaging materials offering improved thermal stability, better moisture protection, greater adhesion, lower modulus, higher strength and even controlled electrical conductivity. As OEMs seek to keep pace with changing markets, process efficiency also has taken its place among fundamental performance criteria.

    In recent years, several trends have contributed to changes in the materials supplier's role. Traditionally, semiconductor OEMs had resources of their own for developing materials and processes. However, changing economics have led to downsizing within many firms, leaving manufacturers with fewer resources. In Asia, many Japanese semiconductor plants are relocating outside the country, and the attendant geographic shift of production and design engineers creates a gap in materials engineering support. Additionally, Taiwanese companies have increased their capabilities greatly, leading many engineers once employed in other countries (especially the United States) to seek positions in Taiwan. All these factors have forced OEMs to prioritize their dwindling resources, with more responsibility shifting toward materials and equipment suppliers.

    Rising Temperatures

    Amidst these changes, developing technology continues to deliver components offering higher speeds and greater power densities than ever before, and architectures continue to shrink. As such, rising temperature has become a key hurdle facing designers. This presents two primary issues: 1) how to design more heat-resistant packages, and 2) how to remove as much heat as possible from specific components or assemblies.

    Initially, materials suppliers approached the problem with off-the-shelf formulations to serve a range of applications. But the number and interaction of the variables involved now requires that OEMs take their cooperation with materials and equipment suppliers to a new level. With the escalating thermal requirements of next-generation designs, every interface becomes an issue, and it seems clear that only a total-solution approach will allow true thermal efficiency to be designed into packages.

    To reduce interfacial resistance and optimize heat dissipation, manufacturers and suppliers have begun reviewing the entire package and recognizing not only the roles played by the package's individual parts, but also how their interaction affects thermal transfer. Materials engineers now work with package designers to evaluate heat spreader coatings, chip passivation, thermal interface materials and other functions of thermal materials.

    From this new approach, a new generation of thermal interface materials has begun to emerge. These include advanced phase-change materials that offer the thermal conductivity of greases and the application ease of pads, without the run-off problems experienced in many grease formulations.

    New Requirements, More Teamwork

    As the standard product line gives way to custom compounds, packaging materials no longer are an off-the-shelf selection based on thermal performance, electrical performance or reliability targets. Suppliers are finding that they can more cost-effectively develop individual formulations that offer a specific mix of physical properties when they more fully understand customer needs by being involved in the ongoing design process. As a result, both suppliers and manufacturers can eliminate the costly and time-consuming process of trial and error.

    Like physical properties, processing characteristics also can be manipulated to best suit an individual manufacturing operation if all the key suppliers are involved from a design's initial stages. Package designers can explore the ramifications of pads vs. dispensed liquids without doing actual product trials.

    The current trend toward shorter product life cycles has shifted the focus of many OEMs away from long-term reliability, driving many to concentrate more on performance and cost. As companies continue their drive for cost reductions and outsourcing becomes an accepted fact of life, key functions in R&D, testing, process evaluation and other areas are likely to become the responsibility of the materials supplier. Given the complexity of the total solution, however, success depends on increasing cooperation levels between all the key partners involved.

    Click here to enlarge image

    Tom Cook, executive director, may be contacted at Dow Corning Corp., 2200 W. Salzburg Rd., Midland, MI 48686-0994; (989) 496-4400; E-mail: [email protected].

    Nov. 27, 2002 — Surface Logix Inc. said it has raised $25 million in a two-part, third round of funding.

    The Boston-based developer of microfabrication and chemistry technologies for drug discovery platforms, said new investor HBM BioVentures led the round, joined by others including the California Public Employees’ Retirement System, Intel Capital and TIAA-CREF. Existing investors Arch Venture Partners, CW Group and Venrock Associates also participated.

    Surface Logix officials said they will use the money to continue development of its Disease Interrogator platform while pursuing partnerships with other companies in the areas of inflammation and oncology.

    Click here to enlarge image

    Nov. 25, 2002 — It’s taken more than 30 years of independent research, millions of dollars and more than a few false starts by different groups, but the scientists at Agile Materials & Technologies Inc. may be the first to finally commercialize a substance known as BST for use in next-generation communications equipment.

    This is why investors led by NextGen Partners recently ponied up $5.7 million to help Agile take its radio frequency (RF) components from laboratory prototype to a full-fledged commercial product. NextGen invested $1.15 million.

    “A lot of people can do things on the bench, but Agile’s been able to prove that they can actually scale up to a manufacturing capacity,” said Peter Grubstein, a general partner at NextGen and Agile board member.

    Click here to enlarge image

    The company recently received the second of two prototype orders totaling more than $200,000. One contract is for phase shifters, which increase signal acceptance angles in military radars, and the other is a wireless application for a civilian manufacturer. The prototype phase shifters have already been shipped, said Chuck Bischof, Agile’s chief executive.

    So, what has Agile succeeded at that eluded so many for so long? Basically, Agile has figured out how to combine BST, which stands for barium, strontium and titanate — three metals mixed to form a composite, ferroelectric material — with thin-film sputtering technology and existing CMOS manufacturing techniques to create a new wave of passive (which means they don’t consume any power), tunable RF components for the electronics industry. At 1 micron, Agile’s RF passive devices are 100 times smaller than current technology can provide. It can fit many more on a chip, saving space and parts in portable G3 applications such as PDAs and cell phones.

    If Agile can pull this off, said Edward Rerisi, director of research at Allied Business Intelligence, the company could stage quite a coup in the RF market. “Everybody (making G3 portables) wants to cut down on the size of components and integrate them as much as possible.”

    Agile’s components also save manufacturers money because they are electronically tunable — a very desirable feature since hand tuning by a technician today is 15-50 percent of total RF component manufacturing cost, Bischof said.

    “By using this type of thin film ferroelectric material (TFFE), our technique provides a high capacitance density so that integrated devices can be much smaller than existing structures for one, and allows electronic tenability for capacitors; and, in that, it will improve performance and enhance the functionality of its applications,” Bischof said.

    This would also be of major importance to RF chip makers, said Rerisi. “(Tuning) is very important. Not only the cost savings is important but the ability to do it effectively for the small size is important.”

    These improvements — combined with the cost-saving benefits manufacturers will find desirable, a multibillion-dollar market and the smarts of company founders Robert York and Chris Elsass of the University of California, Santa Barbara — are what attracted investors at RockPort Capital Partners, said David J. Prend, a partner at the venture capital firm and an Agile board member.

    “Unlike a lot of other people who’ve tried to do things with this material,” Prend said, “they’ve been able to produce very viable, usable devices primarily due to their electrical engineering capabilities.”

    With prototypes in the hands of potential customers, the next step for the fledgling company is hiring enough staff to meet its goals. If things work out, the 11-person firm will have seven new employees by year’s end and a total of 39 by the end of 2003.


    null

    Company file: Agile Materials & Technologies Inc.
    (last updated Nov. 25, 2002)

    Company
    Agile Materials & Technologies Inc.

    Headquarters
    93 Castilian Drive
    Goleta, Calif., 93117

    History
    The company was incorporated in August 1999 and is a spinoff of the University of California, Santa Barbara.

    Industry
    Wireless communications

    Employees
    11

    Small tech-related products and services
    Agile Materials uses thin-film ferroelectric technology to develop variable integrated passive (VIP) components for radio frequency (RF) wireless communications. These components can function at a size 100 times smaller than was previously possible. RF designers benefit from this miniaturization, reduced number of parts and smaller “footprint,” since they can create smaller circuits or simply add functionality to existing circuitry. The components offer even greater cost savings due to their electronic tunability; hand-tuning can account for up to half of RF component manufacturing costs.

    Management

  • Chuck Bischof: chief executive officer
  • Chris Elsass: president
  • Robert York: chief technology officer
  • Selected strategic partners and customers
    Agile Materials has received more than $200,000 in prototype orders from an unnamed defense contractor and a cell phone manufacturer.

    Investment history
    Agile Materials completed a bridge funding round in June 2002, raising $700,000 from Harris & Harris Group, Cycad Group LLC, round leader NextGen Partners and Rockport Capital Partners. NextGen also led the company’s September 2002 funding round, in which the company garnered nearly $5.8 million; the other previous investors participated as well. Prior to receiving venture funding, Agile Materials was awarded $1.25 million in Small Business Innovation Research grant money.

    Barriers to market
    Being a new company with no direct competition, barriers come more from internal milestones that must be met successfully as opposed to outside forces working to retain market share or squelch competition. Specifically, validating the technology by delivering mass-producible products and finding the right people to make it happen.

    Goals
    Validate commercialization of the technology; build a team of people to carry the company forward; select the right customers for the long-term growth, value and health of the company.

    Why they’re in small tech
    “Bottom line is everything is going smaller. If you’re not in small tech then you’ve got some serious problems,” said CEO Chuck Bischof.

    What keeps them up at night?
    “All of the above: being a startup in very competitive, rapidly changing business; being able to keep up and make the right choices and quickly acknowledging when you’ve made a poor one and responding appropriately to correct it.”

    Contact

  • URL: www.agilematerials.com
  • Phone: 805-968-5159
  • Fax: 805-893-5947
  • Recent news
    Agile Materials secures $5.8 million

    — Research by Gretchen McNeely